Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Felix Lindberg

Karolinska Institute, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail

Discussant panel

Presentation thumbnail

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Doctor K. Berge (Nordbyhagen, NO)

Presentation thumbnail

Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

Doctor R. Inciardi (Brescia, IT)

Presentation thumbnail

Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

Doctor A. Villaschi (Milan, IT)

Presentation thumbnail

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Doctor C. Basile (Stockholm, SE)

Access the full session

Session thumbnail

Latest registries and observational studies

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Congress Presentation

Overcoming limitations in using the four pillars in the treatment of HFrEF

Congress Presentation

Real-life management of heart failure: evaluation of medication optimisation in different phenotypes.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources